Normal view MARC view ISBD view

US FDA regulatory requirements for ANDA submission and review phase assessment

Pachipulusu Rajesh

US FDA regulatory requirements for ANDA submission and review phase assessment - 1 - 2019 - 191p.

Pramod Kumar T.M

Subjects--Topical Terms:
Pharmaceutics - Regulations

Dewey Class. No.: 615.4 PAC

Place hold
Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core ISBD MARC (non-Unicode/MARC-8) MARCXML MODS (XML) RIS MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard)
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)